DRK Kliniken Berlin Mitte

Berlin 13359

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Primary Biliary Cholangitis

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment — Recruiting now